SUCCESS RATE

SUCCESS RATE

The GENERA Group is a reference point at national and international level for the high quality of the services offered and for the scientific rigorousness of the protocols applied, as demonstrated by the high number of scientific publicationsproduced by the group every year.

The success of an IVF treatment is defined as the cumulative percentage of ongoing clinical pregnancy achieved compared to the initiated cycle.  Thisindicator takes into account fresh treatments and any treatments performedwith cryopreserved embryos from the same treatment cycle.

Our centre also reports the rate of live birth because the pregnancy rate (without childbirth) is not sufficient to define the results of PMA since it doesnot take into account the risk of miscarriage.

Consistent efficacy and efficiency of the treatments provided...

0

COUPLES RECEIVING TREATMENTS

0

LIVE BIRTH

13772

OOCYTE RETRIEVALS (OPU)

0

EMBRYO TRANSFER (ET)

*Official data reported to the IVF National Register of the Italian Authority (ISS)

GENERA GROUP - Year 2017

CLINICAL PREGNANCY AND LIVE BIRTH RATE PER IVF/ICSI CYCLE

ACCORDING  TO MATERNAL AGE

Although the mean maternal age of patients accessing GENERA centres  issignificantly higher than the national average (38.2 vs 36.7), our treatmentsresult in a higher rate of live birth rate.

AGE <35 :

Clinical pregnancy rate0%
51 %
Live birth rate0%
42 %

AGE 35-39 :

Clinical pregnancy rate0%
38 %
Live birth rate0%
32 %

AGE 40-42 :

Clinical pregnancy rate0%
20 %
Live birth rate0%
16 %

AGE >43 :

Clinical pregnancy rate0%
8 %
Live birth rate0%
4 %

Advanced clinical and laboratory procedures to managethe most challenging cases

The implementation of sophisticated clinical ( customized ovarian stimulation) and laboratory procedures (such as embryo culture up to the blastocyst stage and pre-implantation genetic testing, aimed at acquiring information on the viability and genetic constitution of the embryo) allow to optimize the treatment and identify the embryo with the highest probability of implantation and with the lowest risk of generating an abortion after the transfer.

Since 2013…

(Mean maternal age: 39 years)

0

PGT CYCLES

0%

CYCLES WITH AT LEAST ONE ANALYZED BLASTOCYST

0%

PERCENTAGE OF EMBRYOS WITH NORMAL CHROMOSOMAL STATUS 

0.0%

LIVE BIRTH PER OPU

0%

LIVE BIRTH PER ET

Efficient cryopreservation program

Since  2010 to 2018

(homologous gametes)

0

EMBRYO WARMING CYCLES

0.0%

EMBRYO TRANSFER PERFORMED  

0.0%

LIVE BIRTH PER ET

Efficient oocyte donation program: Since 2015 to 2018

The number of oocytes made at the disposal of the couple is crucial in achieving pregnancy, therefore more than 6 vitrified oocytes per thawing cycle are provided to the couple in our centers.

0

OOCYTE DONATION CYCLES

0.0%

CUMULATIVE LIVE BIRTH PER CYCLE

0.0%

CYCLES WITH SUPERNUMERARY BLASTOCYSTS

Pregnancy rate per ET

(Year 2017) 

0.0%

GENERA GROUP

0.0%

NATIONAL AVERAGE (ISS)

The definition of clinical success cannot ignore the safeguarding of the health of women and of new-born.

The clinical strategies adopted by the GENERA group were very efficient both in reducing the risk of pregnancy loss in women over 35 years of age and in reducing the incidence of twin pregnancies ( thus improving obstetric outcomes compared to the national average).

Reduced risk of pregnancy loss in patients over 35 years of age
 

0.0%

GENERA GROUP

0.0%

NATIONAL AVERAGE (ISS)

REDUCED INCIDENCE OF MULTIPLE PREGNANCY

Our policy of transferring a single blastocyst in women under 35 years of age or a single euploid blastocyst in cases of pre-implantation diagnosis has ensured a significant reduction in the incidence of twin pregnancies and same treatment efficacy in all age groups of the woman.

Multiple pregnancies

(year 2017)

0.0%

GENERA GROUP

0%

NATIONAL AVERAGE (ISS)

IMPROVED OBSTETRICAL OUTCOMES

The adoption of single embryo transfer policies has also improved obstetric outcomes with a reduction in pre-term and underweight babies compared to the national average.

YEAR 2017

PRETERM BIRTH

0.0%

GENERA GROUP

0.0%

NATIONAL AVERAGE (ISS)

YEAR 2017

LOW-WEIGHT BABIES

0.0%

GENERA GROUP

0.0%

NATIONAL AVERAGE (ISS)